Policy & News
World's 2nd RSV vaccine approved for marketing by FDA
2023-06-05
On 31 May, Pfizer announced that its bivalent respiratory syncytial virus (RSV) vaccine, ABRYSVO (RSVpreF, PF-06928316), has been approved for marketing by the FDA for the prevention of lower respiratory tract disease (LRTD) caused by RSV in people 60 years of age and older, making it the second RSV vaccine approved for marketing in the world.
View More
2023-04-29
On 29th April, Kangrun Bio invited Mr. Xue Zhiqiang, a senior lecturer and senior management consultant of Bestray, to conduct the training of "Closed Loop Management" course in the second phase of the Comprehensive Ability Improvement Training Camp for First-Line Supervisors, and 41 first-line supervisors participated in the training.
View More
Management of Adverse Drug Reaction Reporting and Monitoring
2023-04-27
Article 1 In order to strengthen the post-market supervision of medicines, standardise the reporting and monitoring of adverse drug reactions, control the risks of medicines in a timely and effective manner, and safeguard the safety of medicines for the public, these Measures are formulated on the basis of the Drug Administration Law of the People's Republic of China and other relevant laws and regulations.
View More
Drug Manufacturing Supervision and Administration Measures
2023-04-27
The Measures for the Supervision and Administration of Pharmaceutical Production was considered and adopted at the 1st Bureau Meeting of 2020 of the State Administration of Market Supervision and Administration on 15 January 2020, and is hereby promulgated and shall come into force from 1 July 2020 onwards.
View More
2023-04-27
Article 1 This Law is enacted for the purpose of strengthening vaccine management, ensuring the quality and supply of vaccines, regulating preventive vaccination, promoting the development of the vaccine industry, safeguarding public health and maintaining public health safety.
View More
2023-01-09
Recently, after the strict examination and certification by the relevant leaders and experts of Jiangsu Private Science and Technology Enterprises Association, Jiangsu Kangrun Biotechnology Company Limited has been evaluated as "Jiangsu Private Science and Technology Enterprise".
View More
